Kimura S, Kotani T, McBride O W, Umeki K, Hirai K, Nakayama T, Ohtaki S
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5555-9. doi: 10.1073/pnas.84.16.5555.
Two forms of human thyroid peroxidase cDNAs were isolated from a lambda gt11 cDNA library, prepared from Graves disease thyroid tissue mRNA, by use of oligonucleotides. The longest complete cDNA, designated phTPO-1, has 3048 nucleotides and an open reading frame consisting of 933 amino acids, which would encode a protein with a molecular weight of 103,026. Five potential asparagine-linked glycosylation sites are found in the deduced amino acid sequence. The second peroxidase cDNA, designated phTPO-2, is almost identical to phTPO-1 beginning 605 base pairs downstream except that it contains 1-base-pair difference and lacks 171 base pairs in the middle of the sequence. This results in a loss of 57 amino acids corresponding to a molecular weight of 6282. Interestingly, this 171-nucleotide sequence has GT and AG at its 5' and 3' boundaries, respectively, that are in good agreement with donor and acceptor splice site consensus sequences. Using specific oligonucleotide probes for the mRNAs derived from the cDNA sequences hTPO-1 and hTPO-2, we show that both are expressed in all thyroid tissues examined and the relative level of two mRNAs is different in each sample. These results suggest that two thyroid peroxidase proteins might be generated through alternate splicing of the same gene. By using somatic cell hybrid lines, the thyroid peroxidase gene was mapped to the short arm of human chromosome 2.
从一个由格雷夫斯病甲状腺组织mRNA构建的λgt11 cDNA文库中,利用寡核苷酸分离出了两种形式的人甲状腺过氧化物酶cDNA。最长的完整cDNA,命名为phTPO - 1,有3048个核苷酸,其开放阅读框由933个氨基酸组成,这将编码一个分子量为103,026的蛋白质。在推导的氨基酸序列中发现了五个潜在的天冬酰胺连接的糖基化位点。第二个过氧化物酶cDNA,命名为phTPO - 2,除了在序列中间有1个碱基对的差异和缺少171个碱基对外,从下游605个碱基对处开始与phTPO - 1几乎相同。这导致了57个氨基酸的缺失,相当于分子量为6282。有趣的是,这个171核苷酸序列在其5'和3'边界分别有GT和AG,这与供体和受体剪接位点的共有序列高度一致。使用针对源自cDNA序列hTPO - 1和hTPO - 2的mRNA的特异性寡核苷酸探针,我们表明两者在所检测的所有甲状腺组织中均有表达,并且在每个样本中两种mRNA的相对水平不同。这些结果表明,两种甲状腺过氧化物酶蛋白可能是通过同一基因的可变剪接产生的。通过使用体细胞杂交系,甲状腺过氧化物酶基因被定位到人类染色体第2号的短臂上。